Vivos Therapeutics
NASDAQ: VVOS
$0.39 ▲ +0.00  (+0.64%)
At close: Jul 24, 2026 · 4:00 PM UTC
Financial Ratios
Market Cap3.62 Mn
P/E-0.23
P/S0.19
Div. Yield0.00
Total Debt (Qtr)7.72 Mn
Revenue Growth (1y) (Qtr)70.46
Add ratio to table…

About

Vivos Therapeutics Inc is a revenue stage medical technology and healthcare services company that offers a comprehensive suite of proprietary oral appliances and therapeutic treatments known as the Vivos Method. The Vivos Method non surgically treats maxillofacial and developmental abnormalities of the mouth and jaws that are linked to breathing and sleep disorders such as obstructive sleep apnea and snoring in adults. The company also provides diagnostic and treatment…

Read more ↓
Sector: Healthcare Industry: Medical Devices CIK: 0001716166

Product and Service Breakdown of Revenue (2025)

Peer Comparison

Companies in the Medical Devices
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 ABT Abbott Laboratories 201.40 Bn27.984.4634.05 Bn
2 SYK Stryker Corp 122.29 Bn36.604.8414.72 Bn
3 MDT Medtronic plc 105.01 Bn21.732.8927.96 Bn
4 BSX Boston Scientific Corp 64.81 Bn18.163.1411.03 Bn
5 EW Edwards Lifesciences Corp 55.28 Bn2,354.768.770.60 Bn
6 DXCM Dexcom Inc 29.06 Bn29.176.03-
7 PHG Koninklijke Philips Nv 29.02 Bn22.061.429.48 Bn
8 GEHC GE HealthCare Technologies Inc. 28.27 Bn14.301.3510.14 Bn